CClinicalTrials.gg
CompletedNCT05191407Updated Jan 13, 2022

Fear and Anxiety Level in Dental Patients During the COVID-19 Pandemic

An observational study in Fear, Anxiety and COVID-19, sponsored by Zeliha Aytekin. Completed at 1 site in Turkey. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-13.

Sponsored by Zeliha Aytekin · Observational

Study type
Observational
Model
Case-crossover
Time perspective
Cross-sectional
Enrollment
301
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Psychological support may be needed to help patients in the face of emotional disturbances that may be associated with the outbreak and to help them accomplish their fear and anxiety. Due to the increasing fear of COVID-19 transmission during the pandemic, patients may develop treatment avoidance behavior in dental practices. If the fear and anxiety levels of the patients can be determined, it may be easy to offer special approaches to them.

Read the detailed description

Officially, the first COVID-19 case in Turkey was diagnosed on March 10, 2020. To ensure social isolation, cities were locked down with residents to stay at home to prevent disease transmission. A very large part of the population may experience frustration, stress, and irritability while in isolation. Due to the prolonged lockdown and COVID-19 associated fear, the COVID-19 pandemic, which threatens people's physical health and lives, is likely to trigger a wide variety of psychological problems such as anxiety and depression by increasing their stress levels.

The risk of cross-infection in dentistry has been described as considerably high due to close physical contact between dental professionals and patients, and aerosols production during routine dental treatments. In this uncertain process, patients remain undecided about attending their dental appointments. Their concern is associated with the risk of getting infected and transmitting the disease to family members. All these factors may increase the mental stress of patients.

The essential purpose of this study is to evaluate the COVID-19 fear and anxiety level, COVID-19 knowledge status, and information sources in dental patients in Turkey during the pandemic period.

02

Conditions studied

  • Fear
  • Anxiety
  • COVID-19

Keywords

  • COVID-19 Pandemic
  • COVID-19
  • fear
  • anxiety
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 301 is above the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

This is the only study on the registry with Zeliha Aytekin as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of individuals randomly selected from the patients who applied to the Faculty of Dentistry.

Inclusion criteria

  • willing to participate with providing informed consent;
  • age ≥18 years
  • able to understand and read \& write the Turkish language.

Exclusion criteria

Exclusion Criteria:

  • not willing to participate with providing informed consent;
  • age\<18 years
  • not able to understand and read \& write the Turkish language
05

Study design

Observational model
Case-crossover
Time perspective
Cross-sectional
Enrollment
301 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna
06

What researchers measure

Primary outcomes

  1. fear of COVID-19

    The fear of participants is measured by the Turkish validated version of the fear of COVID-19 Scale.

    Time frame: last six month ( from the beggining of the pandemic to time of survey)

  2. anxiety

    The anxiety level of the participants is measured by the Turkish version of Generalized Anxiety Disorder-7 Scale

    Time frame: last two weeks

07

Study locations

1 site
  • Akdeniz University
    Antalya, 07058, Turkey
08

References and documents

Publications

  • Temsah MH, Al-Sohime F, Alamro N, Al-Eyadhy A, Al-Hasan K, Jamal A, Al-Maglouth I, Aljamaan F, Al Amri M, Barry M, Al-Subaie S, Somily AM. The psychological impact of COVID-19 pandemic on health care workers in a MERS-CoV endemic country. J Infect Public Health. 2020 Jun;13(6):877-882. doi: 10.1016/j.jiph.2020.05.021. Epub 2020 May 29. Erratum In: J Infect Public Health. 2020 Oct;13(10):1599. doi: 10.1016/j.jiph.2020.08.012. PubMed 32505461 ↗
  • Al-Rahimi JS, Nass NM, Hassoubah SA, Wazqar DY, Alamoudi SA. Levels and predictors of fear and health anxiety during the current outbreak of COVID-19 in immunocompromised and chronic disease patients in Saudi Arabia: A cross-sectional correlational study. PLoS One. 2021 Apr 26;16(4):e0250554. doi: 10.1371/journal.pone.0250554. eCollection 2021. PubMed 33901260 ↗

Individual participant data

Plan to share: No — There is not a plan to make IPD available.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05191407
Lead sponsor
Zeliha Aytekin
Responsible party
Zeliha Aytekin (Research Assistant, Akdeniz University) — Sponsor-investigator
First posted
Jan 13, 2022
Start date
Sep 23, 2020
Primary completion
Oct 23, 2020
Completion
Oct 23, 2020
Last update
Jan 13, 2022

Study contacts

Özlem Daltaban, PhD
study director · Akdeniz University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion